Cynbiose and Active Biomarkers sign a co-marketing & business agreement

6 December 2021

Cynbiose and Active Biomarkers are pleased to announce that they have entered into a co-marketing and business agreement to strengthen their more than 10-year collaboration.

Active Biomarkers is an international service provider specialized in soluble biomarker analysis and clinical trial immuno-monitoring. The company is specialized in the development, qualification, validation, and small to large scale sample testing of hundreds of assays, supporting regulatory filings of tens of innovative therapies.

Through this agreement, the two companies will copromote their respective services and offer their clients a fully integrated scientific and technical solution to advance innovative therapies in multiple therapeutic areas.

This partnership will enable Cynbiose to provide, a fully  integrated suite of services, including exploratory pharmacokinetics and pharmacodynamics studies, early safety studies, hybrid exploratory designs, biomarkers and efficacy studies using original NHP models to bridge the gap between preclinical and clinical development.


Share this!